Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Long-Term Investments: 2018

Historic Long-Term Investments for Akebia Therapeutics (AKBA) over the last 1 years, with Dec 2018 value amounting to $245,000.

  • Akebia Therapeutics' Long-Term Investments was N/A to $245,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $245,000, marking a year-over-year change of. This contributed to the annual value of $245,000 for FY2018, which is N/A change from last year.
  • According to the latest figures from FY2018, Akebia Therapeutics' Long-Term Investments is $245,000.
  • Akebia Therapeutics' 5-year Long-Term Investments high stood at $245,000 for FY2018, and its period low was $245,000 during FY2018.
  • In the last 1 years, Akebia Therapeutics' Long-Term Investments had a median value of $245,000 in 2018 and averaged $245,000.